Clinical Decision Support Systems Pipeline Report Featuring Over 300 Companies/Universities and Product Developments by Stages of Development, Segments, Region and Countries, Regulatory Path [Yahoo! Finance]
Aclarion, Inc. (NASDAQ: ACON) had its "hold" rating re-affirmed by analysts at Maxim Group.
Winter 2024 Investor Summit Virtual: Q4 Presentations Now Available for On-Demand Viewing
Aclarion, Inc. (NASDAQ: ACON) had its price target lowered by analysts at Ascendiant Capital Markets from $1.50 to $1.30. They now have a "buy" rating on the stock.
Aclarion Announces Nociscan Featured in RSNA Edition of Siemens MAGNETOM Flash [Yahoo! Finance]